Tax credit legislation can pave way for affordable hearing aids

Hearing aids for as many as ten million Americans living with untreated hearing loss could soon become a reality if Congress acts, according to Stephen Hansbrough, CEO of HearUSA (Amex: EAR), one of the nation's largest hearing care companies.

Hansbrough is urging passage of tax credit legislation currently being considered by the House and the Senate that would make hearing aids significantly more affordable.

Although almost all of the 36 million Americans with hearing loss could be helped by hearing aids, only nine million currently use them, the Better Hearing Institute (BHI) reports, citing affordability as the prime reason most go without hearing care and noting that 70 percent of all hearing aid purchases are not supported by insurance.

"Hearing loss is a critical quality of life and health issue and we are committed to seeing hearing care recognized as a medical necessity," said Hansbrough. "HearUSA is supportive of measures that make hearing care more affordable and accessible and that increase public awareness of the scope and impact of hearing loss."

He said that ten million of the 27 million Americans with untreated hearing loss would be likely to purchase hearing aids if $500 tax credits were available, according to a nationwide survey conducted by the BHI.

Both the Senate (S. 109) and House (H.R. 1646) Hearing Aid Tax Credit Acts provide for a tax credit of up to $500 for each hearing aid once every five years. The House measure would apply to taxpayers 55 or over and for those purchasing hearing aids for a dependent, while the Senate version would have no age restriction.

Hansbrough said the hearing aid tax credit is supported by leading health care and advocacy organizations, including the Better Hearing Institute, the Hearing Loss Association of America, the American Academy of Audiology and AARP.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Dietitians boost GLP-1 therapy success with personalized care and side effect management